Galectin Therapeutics
GALT
#7577
Rank
HK$3.01 B
Marketcap
HK$46.83
Share price
4.88%
Change (1 day)
215.17%
Change (1 year)

EPS for Galectin Therapeutics (GALT)

EPS in 2025 (TTM): -HK$5.07

According to Galectin Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$5.06. In 2024 the company made an earnings per share (EPS) of -HK$5.91 a decrease over its 2023 EPS that were of -HK$5.76.

EPS history for Galectin Therapeutics from 2001 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$5.07-14.25%
2024-HK$5.912.7%
2023-HK$5.7613.85%
2022-HK$5.0625%
2021-HK$4.0526.83%
2020-HK$3.195.13%
2019-HK$3.032.63%
2018-HK$2.96-22.45%
2017-HK$3.81-35.53%
2016-HK$5.91-13.64%
2015-HK$6.8512.82%
2014-HK$6.07-40%
2013-HK$10.1180.56%
2012-HK$5.60-32.08%
2011-HK$8.2513.98%
2010-HK$7.23-22.5%
2009-HK$9.34185.71%
2008-HK$3.27-70.83%
2007-HK$11.20118.18%
2006-HK$5.13-54.17%
2005-HK$11.20-14.29%
2004-HK$13.0747.37%
2003-HK$8.87-13.64%
2002-HK$10.27-24.14%
2001-HK$13.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Mirati Therapeutics
MRTX
-HK$95.06 1,780.00%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
HK$0.78-115.38%๐Ÿ‡บ๐Ÿ‡ธ USA